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Toll-like receptors (TLRs) and NOD-like receptors (NLRs) are innate immunity sensors
that provide an early/effective response to pathogenic or injury conditions. We have
reported that ethanol-induced TLR4 activation triggers signaling inﬂammatory responses
in glial cells, causing neuroinﬂammation and brain damage. However, it is uncertain if
ethanol is able to activate NLRs/inﬂammasome in astroglial cells, which is the mechanism
of activation, and whether there is crosstalk between both immune sensors in glial
cells. Here we show that chronic ethanol treatment increases the co-localization of
caspase-1 with GFAP+ cells, and up-regulates IL-1β and IL-18 in the frontal medial cortex
in WT, but not in TLR4 knockout mice. We further show that cultured cortical astrocytes
expressed several inﬂammasomes (NLRP3, AIM2, NLRP1, and IPAF), although NLRP3
mRNA is the predominant form. Ethanol, as ATP and LPS treatments, up-regulates
NLRP3 expression, and causes caspase-1 cleavage and the release of IL-1β and IL-18
in astrocytes supernatant. Ethanol-induced NLRP3/caspase-1 activation is mediated by
mitochondrial (m) reactive oxygen species (ROS) generation because when using a speciﬁc
mitochondria ROS scavenger, the mito-TEMPO (500 μM) or NLRP3 blocking peptide
(4 μg/ml) or a speciﬁc caspase-1 inhibitor, Z-YVAD-FMK (10 μM), abrogates mROS release
and reduces the up-regulation of IL-1β and IL-18 induced by ethanol or LPS or ATP. Confocal
microscopy studies further conﬁrm that ethanol, ATP or LPS promotes NLRP3/caspase-1
complex recruitment within the mitochondria to promote cell death by caspase-1-mediated
pyroptosis, which accounts for ≈73% of total cell death (≈22%) and the remaining (≈25%)
die by caspase-3-dependent apoptosis. Suppression of theTLR4 function abrogates most
ethanol effects on NLRP3 activation and reduces cell death. These ﬁndings suggest that
NLRP3 participates, in ethanol-induced neuroinﬂammation and highlight the NLRP3/TLR4
crosstalk in ethanol-induced brain injury.
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INTRODUCTION
Inﬂammation in the central nervous system (CNS), or
neuroinﬂammation, is a key component of many neu-
rological and neurodegenerative disorders characterized by
lymphocyte/macrophage inﬁltration, glial activation, enhanced
cytokine/chemokine production, demyelination and axonal loss
(Sospedra and Martin, 2005; Pittock and Lucchinetti, 2007). The
neuroinﬂammatory process is initiated by several receptors of
the innate immune system, which recognize a diverse range of
microbial and damage signals, coordinate protection and repair
mechanisms.
Toll-like receptors (TLRs) andnucleotide-bindingoligomeriza-
tion domain (NOD)-like receptors (NLRs) are two major forms
of innate immune sensors which provide immediate responses
against pathogenic invasion, tissue injury and stress conditions.
Both the TLRs and NLRs families of receptors are activated
through the recognition of both conserved microbial struc-
tures, called pathogen-associatedmolecular patterns (PAMPs) and
damage-associated molecular patterns (DAMPs). However, unlike
membrane-bound TLRs that sense PAMPs or DAMPs on the cell
surface orwithin endosomes,NLRs recognizemicrobialmolecules
orDAMPs in the host cytosol. Activationof these receptors induces
the recruitment of innate immune cells, which initiates tissue
repair processing and adaptive immune activation. Abnormalities
in any of these innate sensor-mediated processes may cause exces-
sive inﬂammation due to either hyper-responsive innate immune
signaling or sustained compensatory adaptive immune activation.
NOD-like receptors family members, NLRP1, NLRP3, NLRC4,
and AIM2 (a member of the PYHIN protein family), have been
identiﬁed as being capable of forming inﬂammasomes, multipro-
tein complexes that activate caspase-1, which leads to the process-
ing and secretion of pro-inﬂammatory cytokines interleukin-1β
(IL-1β) and IL-18. Among NLRs, NLRP3 is currently the most
fully described inﬂammasome. It consists of the NLRP3 scaffold,
adaptor ASC (apoptosis-associated speck-like protein containing
a CARD) and caspase-1. Nevertheless, the molecular and cellular
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mechanisms of NLRP3 activation remain unclear. Differentmech-
anisms have been postulated, such as lysosomal damage (Hornung
and Latz, 2010), potassium leakage (Arlehamn et al., 2010), and
reactive oxygen species (ROS) formation (Schroder et al., 2010;
Shimada et al., 2012a). Recent studies support the role of mito-
chondrial adaptors (Subramanian et al., 2013), mitochondria
calciumﬂuxes (Triantaﬁlou et al., 2013) andROS formation (Zhou
et al., 2011; Shimada et al., 2012b) in inﬂammasome activation.
NOD-like receptors P3 is activated upon exposure to whole
pathogens, but also by a number of host-derived danger signals,
which are indicative of not only tissue injury (DAMPs), but also
environmental irritants (Schroder and Tschopp, 2010). Mutation
of NLRP3 is responsible for rare autoinﬂammatory diseases, col-
lectively referred to as cryopyrin-associated periodic syndromes
(CAPS; Neven et al., 2004; Ting and Davis, 2005; Jha and Ting,
2009), characterized by the hyperactivation of the inﬂammasome
complex and increased IL-1β (Neven et al., 2004; Goldbach-
Mansky et al., 2006). In addition, there is emerging evidence for
the participation of the NLRP3 inﬂammasome as a sensor of
metabolic stress (i.e., De Nardo and Latz, 2011), demyelination,
and it is also involved in some neurodegenerative disorders such
as the multiple sclerosis model (Jha et al., 2010) and Alzheimer’s
disease (Heneka et al., 2013; Sheedy et al., 2013; Tan et al., 2013).
Alcohol is a neurotoxic compound and its abuse can induce
brain damage and neurodegeneration. We have demonstrated
that ethanol is capable of activating TLR4/IL-1RI receptors in
astroglial and microglial cells to trigger TLR4 signaling and to pro-
duce cytokines induction (IL-1β, TNF-α, IL-6) and inﬂammatory
mediators (iNOS, COX-2), which can lead to neuroinﬂammation
and brain injury. Elimination of the TLR4 function abolishes most
neuroinﬂammation and neural death (Alfonso-Loeches et al.,
2010). Our recent studies have further demonstrated that neu-
roinﬂammation induced by ethanol abuse in mice is associated
with demyelination and disruptions in the myelin structure and
that these alterations are, in part, dependent on TLR4 signaling
(Alfonso-Loeches et al., 2012).
Crosstalk between TLRs and NLRs in the secretion of
mature IL-1β during microbial infection has been reported
(Kahlenberg et al., 2005; Becker and O’Neill, 2007; Mariathasan
and Monack, 2007), although it is unknown whether this crosstalk
occurs in brain damage and demyelination. A recent study
shows that ethanol activates NLRP3 inﬂammasome in the brain
(Lippai et al., 2013). However, the cellular and molecular mecha-
nisms of ethanol-induced inﬂammasome activation in the brain
and glial cells, and the interactions of TLRs and NLRs, are
presently unknown. Here we present evidence for NLRP3 expres-
sion in astrocytes and that by stimulating mitochondria ROS
(mROS) generation, ethanol,ATP or LPS triggers NLRP3/caspase-
1 activation and the production of IL-1β and IL-18 in astro-
cytes. These ﬁndings further demonstrate that ethanol promotes
NLRP3/caspase-1 co-localization within mitochondria to trigger
pyroptosis and a small proportion of apoptosis. Elimination of the
TLR4 function reduces the damaging actions of ethanol onNLRP3
inﬂammasomeactivation in astroglial cells in bothprimary culture
and cerebral cortex in vivo, suggesting that TLR4 plays a key role in
ethanol-inducedNLRP3 activation, neuroinﬂammation and brain
damage.
MATERIAL AND METHODS
MICE AND ETHANOL TREATMENT
Female C57BL/6 WT (Harlan Ibérica S.L., Barcelona) and TLR4
knockout (TLR4-KO) mice (C57BL/6 background, kindly pro-
vided by Dr. S. Akira, Osaka University, Japan) were used. Animals
were kept under controlled light and dark conditions (12/12 h) at
a temperature of 23◦C and at 60% humidity. All the animal exper-
iments were carried out in accordance with the guidelines set out
in European Communities Council Directive (86/609/ECC) and
Spanish Royal Decree 1201/2005. The experimental procedures
were approved by the Ethical Committee of Animal Experimenta-
tion of thePrince FelipeResearchCenter (Protocol numbers 08-0060
and 08-0099) and were in accordance with the recommendations
in the ARRIVE Guidelines for the care and use of experimental
animals.
For chronic ethanol treatment, 40 (10 animals/group) 7-week-
old C57BL/6 (WT/TLR4+/+) and TLR4-KO mice weighing 18–
20 g were housed (four animals/cage), and were maintained with
water (WT and TLR4-KO control) or water containing 10% (v/v)
ethanol, and were placed on a solid diet ad libitum for 5 months.
BRAIN TISSUE PREPARATION
Mice were deeply anesthetized by an intraperitoneal injection with
sodium penthobarbital (60 mg/kg) and fentanyl (0.05 mg/kg) for
analgesia. Animals were then transcardially perfused with 0.9%
saline containing heparin (2 U/ml), immediately followed by 4%
paraformaldehyde (PF) in 0.1 M phosphate buffer, pH 7.4, for
tissue ﬁxation to be post-ﬁxed overnight at 4◦C in 4% PF and
stored in 30% sucrose solution at 4◦C for cryoprotection. Coronal
brain sections (40 μm) were obtained with a cryostat (Microm
HM 505E) and were collected on polysineTM glass slides (Menzel-
Gläser, Thermo Scientiﬁc, Germany).
Some mice were killed by cervical dislocation; brains were
removed, dissected using the mouse brain atlas coordinates
(Franklin and Paxinos, 1997), and immediately snap-frozen in
liquid nitrogen until used in the Western blot, RT-PCR, caspase-1
enzymatic activity and cytokines determination analyses.
IMMUNOFLUORESCENCE
(i) Double co-localization of caspase-1 and GFAP in cortical astro-
cytes*: cortical brain sections were defrosted for 30 min and
incubated with 0.25% Triton in PBS solution for 10 min. Sections
were blocked for 1 h/RT with 10% normal goat serum in TBS/T
(0.1%) and were incubated overnight at 4◦C with the follow-
ing primary antibodies; anti-caspase-1 (1/50, Santa Cruz) and
anti-GFAP (1/400, Sigma–Aldrich) following incubation with the
respective Alexa-ﬂuor-conjugated secondary antibodies (1/500,
Invitrogen, Molecular Probes). Nuclei were stained with DAPI.
Negative controls were performed by replacing the respective
primary antibodies with IgG isotype control and concentration-
matched irrelevant antibodies (Figure 1F). Sectionsweremounted
onto glass slides with Dako Fluorescent Mounting medium (Dako
North America Inc., CA, USA). All the images were analyzed
with the ImageJ 1.42 software (NIH). We determined ﬂuorescence
intensity of three different animals per group by randomly taking
four medial-frontal-cortex sections for each one. At least 800–
1000 cells were counted per experimental condition. (ii) Double
Frontiers in Cellular Neuroscience www.frontiersin.org August 2014 | Volume 8 | Article 216 | 2
Alfonso-Loeches et al. Ethanol activates NLRP3 in astrocytes
FIGURE 1 | Chronic ethanol intake increases caspase-1 activity in cortical
astroglial cells ofTLR4 mice. (A–D) Confocal images illustrate the
co-localization of caspase-1 (red) with GFAP (green) in the cortex area (E) of
TLR4+/+ (A,B) andTLR4−/− (C,D) mice (arrows indicate co-localization of
the Casp-1 and GFAP-positive cells). (F) Confocal negative controls, in the
absence of primary antibodies.We used four independent biological
replicates from each experimental condition. Scale bar: 75 μm. (G)The
quantitative analysis shows the percentage of the increased number of
Casp-1/GFAP-positive co-localized cells in the cortices of ethanol-treatedWT
mice in relation to the untreated control mice. Non-signiﬁcant changes were
observed for the treated/untreatedTLR4−/− (TLR4-KO) mice. (H) Caspase-1
enzymatic activity was determined in the brain cortex. (I,J)The analysis of the
IL-1β and IL-18 cytokines in the cortical homogenates of TLR4 mice was
conducted by ELISA. Values represent the [mean ± SEM] of at least six to
eight individual experiments.*p < 0.05, **p < 0.01 (Mann–Whitney U
non-parametric test or a Student’s t -test).
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labeling of NLRP3-inﬂammasome and GFAP in cultured astrocytes*.
Treated/untreated astroglial cells were previously incubated with
0.25% Triton in PBS solution for 10 min for cellular permeabi-
lization. Cells were then blocked for 1 h at room temperature
with 10% normal goat serum in TBS/T (0.1%), and were incu-
bated overnight at 4◦C with the following primary antibodies;
anti-NLRP3 (1/150, AdipoGen) and anti-GFAP (1/400, Sigma–
Aldrich), following incubation with the respective Alexa-ﬂuor-
conjugated secondary antibodies (1/500, Invitrogen, Molecular
Probes). Nuclei were stained with DAPI. All the negative controls
were also performed as described above (i). Cells were mounted
onto glass slides with Dako Fluorescent Mounting medium (Dako
NorthAmerica Inc., CA,USA), and confocal images were analyzed
with the ImageJ 1.42 software (NIH). All the confocal images were
acquired using the same settings, while ﬂuorescence distribution
was acquiredwith a Leica TCS-SP2-AOBA confocal laser-scanning
microscope (Leica Microsystems, Heidelberg GmbH, Mannheim,
Germany) using the 10× Plan-HCX PL APO CS10 and the 40×
Plan-HCX PL APO CS40 × 1.25 oil objectives. All the confocal
images were acquired with the same settings and the ﬂuorescence
distributions were analyzed by the Leica Confocal Software “Leica
Lite,” version 2.61.
CASPASE-1 ASSAY ACTIVITY
Caspase-1 activity was measured by the Colorimetric Assay Kit
(Abcam). This assay allows the detection of chromophore p-
nitroanilide (pNA) after cleavage from labeled substrate YVAD-
pNA, performed following the manufacturer’s instructions. pNA
light emission was quantiﬁed by a spectrophotometer at 405 nm.
The comparison of the absorbance of pNA from treated vs.
untreated controls allowed the determination of the fold increase
in caspase-1 activity.
PRIMARY CULTURE OF ASTROCYTES AND TREATMENTS
Primary cultured astrocytes of mice cortices (WT or TLR4-KO)
from newborn pups were prepared and characterized as previ-
ously described (Minana et al., 2000). Cells were plated on 60-mm
diameter plates in Dulbecco’s modiﬁed Eagle’s medium (DMEM,
Gibco Invitrogen Corporation, Barcelona) containing 20% FBS,
supplemented with L-glutamine (1%), glucose (1%), fungizone
(1%), and antibiotics (1%). Cultures were grown in a humidiﬁed
atmosphere of 5% CO2/95% air at 37◦C. After 1 week of cul-
ture, FBS was reduced to 10%, and the medium was changed
twice a week. Cells were grown to conﬂuence and were used
after 12 days in culture. The purity of astrocytes was assessed
by immunoﬂuorescence using: anti-glial ﬁbrillary acidic protein
(anti-GFAP, astrocyte marker, Sigma-Aldrich, Madrid, Spain),
anti-CD11b (microglial marker, Serotec, Bionova,Madrid, Spain),
anti-myelin basic protein (MBP, olygodendroglial marker, Sigma–
Aldrich, Madrid, Spain) and anti-microtubule-associated protein
2 (MAP-2, neuronal marker, Sigma–Aldrich, Madrid, Spain).
Astrocyte cultures were found to be at least 98% GFAP-positive
and 2% CD11b-positive.
To assess the effect of ethanol (EtOH; 10 or 50 mM),
lipopolysaccharide (LPS; 50 ng/ml) or ATP (5 mM), these com-
pounds were added to DMEM in the absence of serum, but in the
presence of 1 mg/ml bovine serum albumin. After 24 h of LPS,
ATP or ethanol treatments, cells were harvested by trypsinization,
centrifuged and used for speciﬁc determinations. The medium
was used for cytokine determination.
In some experiments, astrocytes were incubatedwith amedium
containing Z-YVAD-FMK (10 μM), a potent cell permeable and
irreversible caspase-1 inhibitor (ICE; Parajuli et al., 2013; Tseng
et al., 2013) orwith Z-VAD-FMK (20μM),a pan-caspase inhibitor
(Dostert et al., 2009) or NLRP3 blocking peptide (bp; 4 μg/ml;
Abcam) or Mito-TEMPO (500 μM), a ROS scavenger, for 30 or
60 min (for Mito-TEMPO) before and during ethanol (50 mM),
or with ATP (5 mM) or LPS (50 ng/ml) treatments. Caspase-1
enzymatic activity, ROS release, IL-1β and IL-18 cytokines were
determined in cells after 24 h treatments. Sterile toxin-free cul-
ture materials were used for all the experiments. In addition,
the possible contamination of ethanol with LPS was determined
by using the chromogenic limulus amebocyte lysate test, follow-
ing the manufacturer’s instructions (Lonza Verviers SPRL). The
endotoxin content in ethanol solution was 2.98 × 103 pg/ml,
which is far below the concentration required to induce astroglial
activation under our assay conditions, as previously described
(Alfonso-Loeches et al., 2010).
FLUORESCENCE-ACTIVATED CELL SORTING (FACS)
MitoSOXTM red mitochondrial superoxide indicator
To evaluate superoxide production by mitochondria, the
MitoSOXTM Red reagent (1.25μM,Molecular Probes) was used in
live cells, a ﬂuorogenic dye speciﬁcally targeted to mitochondria in
live cells. This reagent is readily oxidized by superoxide, but not by
other ROS- or reactive nitrogen species (RNS)-generating systems.
Oxidation of MitoSOXTM Red reagent by superoxide produces
red ﬂuorescence. For these experiments, astrocytes were incu-
bated for 24 h with different treatments; ethanol (10, 50 mM),
LPS (50 ng/ml), ATP (5 mM) or rotenone (25 μM) as the pos-
itive controls, and with inhibitors Z-YVAD-FMK (Calbiochem)
or NLRP3 bp or Mito-TEMPO. Then cells were further incu-
bated with MitoSOXTM (1.25 μM) for 30 min at 25◦C in the
darkness. Cell samples were acquired with a Cytomics FC500
ﬂow cytometer (Beckman-Coulter, USA) equipped with 488 and
635 nm lasers detectors for forward scatter (FS) and side scatter
(SS).Wedeﬁned the cell populationwith the FS and SS parameters,
MitoSOX Red was excited by laser at 488 nm, and its ﬂuores-
cence emission was collected at 620 nm. In order to perform the
analysis in live cells, a gate in the dot plot FS vs. SS was used,
where cell debris was gated out for the analysis. We also used
the LIVE/DEAD® Fixable Near-IR Dead Cell Stain Kit (Molecular
Probes) to determine the viability of cells, and only the live cell
population was used for the analysis. Data were represented as the
[mean ± SEM], showing the percentage of gated mean intensity
of MitoSOX ﬂuorescence expressed as a percentage when com-
paring untreated or DMSO vehicle control-cells with MitoSOX
positive-cells.
AN IN CELL ANALYZER FOR CELLULAR DEATH DETECTION
The six-well plated cultured cells were incubated with the red
caspase-1 detection probe, 660-YVAD-FMK (FLICA) following
the manufacturer’s instructions (ImmunoChemistry Technolo-
gies, USA). Cells were washed with 4◦C PBS before adding the
Frontiers in Cellular Neuroscience www.frontiersin.org August 2014 | Volume 8 | Article 216 | 4
Alfonso-Loeches et al. Ethanol activates NLRP3 in astrocytes
500 μl Annexin-binding buffer containing 2.5 μl of Annexin-
V ﬂuorescein isothiocyanate (FITC) and Hoechst (5 μg/ml) for
30 min of incubation. Finally, we added 1 μl propidium iodide
(PI) solution for a further 5-min incubation in the dark. The
stained samples were imaged live in an In Cell Analyzer 1000 high-
content analysis system (GE Healthcare Life Sciences) equipped
with a CCD camera and a 10×/0.45 NA objective. The 51008
polychroic mirror set was used in conjunction with the following
excitation (×) and emission (m) ﬁlter combinations: 405/20×,
535/50m for Hoechst 33342, 475/20×, 535/50 m for Annexin-
V FITC, 475/20×, 620/60 m for PI and 620/60×, 700/75 m
for FLICA 660-YVAD-FMK. For the analysis, we deﬁned a seg-
mentation based on nuclei staining with Hoechst 33342. Then
we established four groups in order to classify ﬁve populations:
(1) Live cells were deﬁned as negative cells for PI and normal
staining with Hoechst 33342; (2) Apoptotic cells were deﬁned
as negative cells for PI and nuclei with increased staining with
Hoechst 33342 (due to DNA condensation); (3) Necrotic cells
were deﬁned as positive for PI and negative for FLICA 660-
YVAD-FMK staining; (4) pyroptotic cells were deﬁned as double
positive for PI and FLICA 660-YVAD-FMK. Twenty ﬁelds were
acquired for each well. Four different experiments were per-
formed and approximately 2000–10,000 cells were analyzed per
experimental condition. The analysis was performed in the In
Cell Analyzer 1000 Workstation software using the Multi Target
Analysis Module.
MITOTRACKER LIVE CELLS STAINING AND CO-LOCALIZATION STUDIES
IN ASTROGLIAL CELLS
The astrocytes in primary culture were incubated for 10 min at
37◦C with the MitoTracker® Red CMXRos probe (50 nM, Molec-
ular Probes, USA). This probe passively allows diffusion across
the plasma membrane and is accumulated in active mitochon-
dria. Cells were then treated with an aldehyde-based ﬁxative, 3.7%
of paraformaldehyde to allow further sample processing. For the
co-localization studies, the cells stained with MitoTracker were
immunostained with NLRP3 and with caspase-1 activity labeling.
For this end, cells were incubated for 10 min in PBS contain-
ing 0.1% Triton X-100, rinsed off with PBS (1×) and blocked
for 1 h/RT with 10% normal goat serum in TBS/T (0.1%). After
blocking, sections were incubated with the mouse monoclonal
anti-NLRP3 (1/150, AdipoGEN) followed by Alexa ﬂuor 405
(1/500, Molecular Probes). Then sections were incubated with
caspase-1 ﬂuorescence activity using the FAM-FLICATM Caspase-
1 assay kit (ImmunoChemistry Technologies, USA). For this
labeling, cells were incubated for 1 h at RT with the ﬂuorescent
FAM-YVAD-FMK FLICA reagent following the manufacturer’s
instructions (ImmunoChemistryTechnologies,USA).The reagent
becomes covalently coupled to the active enzyme and is retained
within the cell, while the unbound FAM-YVAD-FMK FLICA
reagent diffuses out of the cell and is washed away. The remaining
green ﬂuorescent signal is a direct measure of active caspase-
1 enzyme activity. All the negative controls were performed by
replacing the respective primary antibodies with isotype and
concentration-matched irrelevant antibodies.
Sectionsweremountedonto glass slideswith FluorSaveReagent
(Calbiochem, USA). All the images were acquired using the same
settings under a Leica TCS-SP2-AOBA confocal laser-scanning
microscope (Leica Microsystems, Heidelberg GmbH, Mannheim,
Germany) employing the 63× N.A. 1.4 oil objective. All the
confocal images were acquired with the same settings and ﬂuo-
rescence distribution was analyzed by the Leica Confocal Software
“Leica Lite,” version 2.61. Graphs represent the number of cellular
co-localizations expressed as a percentage (%) of mitochondria
co-localized with the NLRP3 receptor or the NLRP3 receptor
with caspase-1 activity after the different treatments had been
applied.
CYTOKINES DETECTION
The supernatant medium from the 24 h-treated astrocytes and
lysates from the brain cortices were used for cytokine determi-
nations. Brain tissue was homogenized in cold lysis buffer (1%
NP-40, 20 mM Tris-HCl, pH 8, 130 mM NaCl, 10 mM NaF,
10 μg/ml aprotinin, 10 mg/ml leupeptin, 10 μM DTT, 1 mM
Na3VO4 and 1 mM PMSF; 250 mg tissue/0.5 ml). Lysis samples
were kept on ice for 30 min and were centrifuged at maximum
speed for 15 min, and the supernatant was collected for pro-
tein and cytokines determination. Protein was determined by the
Bradford Assay (Bio-Rad, Hercules, CA, USA). The cytokine lev-
els of IL-18 and IL-1β were measured using the enzyme-linked
immunosorbent assay (ELISA) kits (Bender MedSystems GmbH,
Austria) following the manufacturer’s instructions.
WESTERN BLOT ANALYSIS
The protein extracts from the cortex and cultured astrocytes were
homogenized in 250 mg tissue/0.5 ml cold lysis buffer (see above).
Then they were kept on ice for 30 min, centrifuged at maximum
speed for 15 min, and the supernatant was collected to determine
the proteins levels using the Bradford Assay (Bio-Rad, Hercules,
CA, USA). Lysates were separated by SDS-PAGE gels and were
transferred to PVDF membranes following standard techniques.
Membranes were blocked with 5% non-fat dried milk in TBS con-
taining 0.1% Tween-20 (TBS-T). Next they were then incubated
overnight with the following primary antibodies: anti-NLRP3
(1 μg/ml, Abcam), anti-caspase-1 (1/100, Santa Cruz Biotechnol-
ogy); anti-pro-caspase-1 (1/200, Abcam); anti-Apaf-1 (1 μg/ml,
Millipore Bioscience Research Reagents); anti-caspase-3 (1:500)
and anti-caspase-9 (1:1000, Cell Signaling).
Some membranes were stripped for 1 h at 60◦C in an SDS solu-
tion (2% SDS, 0.85% 2-ME, and 65 mM Tris-HCl, pH 6.8, and
were washed and incubated with anti-GAPDH (1/3000, Chemi-
con) for 2 h as a loading control. The intensity of the bands was
quantiﬁed with the image analysis program, α-Ease FC, version α
Imager 2200 (Alpha Innotech Corporation).
ASC OLIGOMERIZATION ASSAY
Apoptosis-associated speck-like protein containing a CARD
pyroptosome were performed following the procedure of
(Fernandes-Alnemri and Alnemri, 2008) with minor modiﬁca-
tions. Thus, astrocytes were seeded in 50-mm diameter plates
(1 × 106 cells per well) and treated with different stimuli. Cells
were pelleted by centrifugation and resuspended in 0.5 ml of ice-
cold buffer containing PBS/Triton 0.5%, and lysed by shearing 10
times. Cell lysates were then centrifuged at 8000 × g for 15 min
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at 4◦C, and the resultant pellets were washed twice with PBS and
resuspended in 200 μl of PBS. The resuspended pellets, were then
cross-linked with fresh disuccinimidyl suberate (DSS; 2 mM) for
30 min at room temperature, and pelleted by centrifugation at
8000 × g for 15 min. The cross-linked pellets were resuspended
in 30 μl of SDS sample buffer, separated using 12% SDS-PAGE
and immunoblotted employing anti-mouse ASC antibodies. The
dimer band was quantiﬁed by densitometry.
CO-IMMUNOPRECIPITATION OF NLRP3 AND CASPASE-1
Pre-cleared cell lysates were used for the co-immunoprecipitation
(Co-IP) analysis using a Pierce Co-IP kit (Thermo Scientiﬁc
Pierce) and following the manufacturer’s instructions. This kit
provides covalent antibody immobilization onto an insoluble
agarose support, and then incubated with a cell lysate contain-
ing the target protein. We use the purify mouse anti-NLRP3
antibody (10 μg, AdipoGEn) to immunoprecipitate the antigen
(bait protein, IB) which bind the interacting protein (prey pro-
tein, IP) caspase-1 (1/100, Santa Cruz). Upon elution the immune
complexes, the samples were resolved with 15% SDS-PAGE and
transferred to PVDF membranes (Bio-Rad) for immunoblotting.
The mouse IgG was used as a negative control.
LACTATE DEHYDROGENASE (LDH) ACTIVITY
The release of LDH in the culture supernatant of astrocytes was
measured using the colorimetric Cyto-Tox 96 Non-radioactive
Assay (Promega) following the manufacturer’s instructions. This
assay is a coupled enzymatic assay, which results in the conver-
sion of a tetrazolium salt into a formazan product which, in
turn, is proportional to the number of lysed cells. We used tri-
ton X-100 as a positive control. The LDH value was expressed as
the percentage of total LDH activity, according to the following
equation: %LDH release rate = 100 × [(Experimental − Effector
Spontaneous − Target Spontaneous)/(Target Maximum − Target
Spontaneous)].
TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE dUTP NICK END
LABELING (TUNEL)
To assess cellular apoptosis (programmed cell death), we used
the in Situ Cell Death Detection Kit (Roche), Fluorescein. In
brief, coverslips with adherent cells were ﬁxed and perme-
abilized (see Immunoﬂuorescence) following incubation in a
nucleotide mixture containing ﬂuorescein-dUTP and TdT (ter-
minal transferase), according to the manufacturer’s instructions.
Cell nuclei were detected by incubation with DAPI. Micro-
graphs were digitally recorded with a Leica DM6000 FS ﬂuores-
cence microscope. TUNEL-positive cells appeared green, whereas
TUNEL-negative nuclei appeared blue. Negative controls were
incubated without TdT. The percentage of TUNEL-positive cells
vs. TUNEL-negative cells was quantiﬁed for each experimental
condition.
RNA ISOLATION, REVERSE TRANSCRIPTION PCR AND
QUANTIFICATION OF mRNA LEVELS
RNA was extracted from the cortex brain area using Trizol accord-
ing to the manufacturer’s instructions (Sigma). RNA was mea-
sured in a NanoDrop ND-1000 Spectrophotometer (260/280 nm
ratio). First-strand cDNA synthesis was performed with the
Transcriptor First Strand cDNA Synthesis Kit (Roche Applied
Biosystems) using 2000 ng of total RNA according to themanufac-
turer’s instructions. The RT-PCR reactions contained LightCycler
480 SYBR Green I Master (2×; Roche Applied Science), 5 μM
forward and reverse primers, and 1 μl of cDNA. RT-PCR was
performed in a LightCycler® 480 System (Roche). The ampli-
ﬁcation efﬁciency (E) of the primers was calculated from the
plot of the Cq values against the cDNA input according to the
equation E = [10(−1/slope)]. The relative expression ratio of a
target/reference gene was calculated according to the Pfafﬂ equa-
tion (Pfafﬂ, 2001). The sequence of both the forward and reverse
primers used in this study is detailed in Table 1. Housekeeping
cyclophilin A (PPIA) was used as an internal control. Fluorescence
was recorded in the annealing/elongation step in each cycle. A
melting curve analysis was performed at the end of each PCR to
check the speciﬁcity of the primers.
STATISTICAL ANALYSIS
Datawere analyzed using aMann–WhitneyU non-parametric test
or one-wayANOVA followed by aDunnett’sMultiple Comparison
or a Student’s t-test (SPSS program, version 17.0). Differences at
a value of p < 0.05 were considered statistically signiﬁcant
RESULTS
ETHANOL ACTIVATES THE NLRP3 INFLAMMASOME-COMPLEX
FORMATION IN ASTROGLIAL CELLS FROM CEREBRAL CORTEX AND
PRIMARY CULTURE
Glial cells are important players in the immune response in the
CNS (Farina et al., 2007). Our previous studies demonstrated that
ethanol activates TLR4 signaling in astrocytes (Blanco et al., 2005;
Alfonso-Loeches et al., 2010). We therefore wondered if ethanol
was also capable of activating the inﬂammasome in astroglial
cells to contribute to ethanol-induced neuroinﬂammation. To
answer this question, we ﬁrst evaluated whether ethanol treat-
ment promotes caspase-1 activation and the release of interleukins
IL-1β and IL-18 in both cerebral cortex (Ctx) area (Figure 1E)
and in cortical astroglial cells (Figure 2C). The biochemical
and immunohistochemical analyses revealed that chronic ethanol
treatment increases the co-localization of caspase-1 with GFAP-
positive cells (Figures 1B,G) and up-regulates the total caspase-1
activity levels (Figure 1H) in the cerebral Ctx of WT mice when
Table 1 | Gene primer sequences.
Gene Sequences cDNA size Tm
NLRP3-F GGGCTTCTGCACCCGGACTG 328 65◦
NLRP3-R GGTGGTCCTGCTTCCACGCC 328 65◦
AIM2-F GTCACCAGTTCCTCAGTTGTG 259 60◦
AIM2-R TGTCTCCTTCCTCGCACTTT 259 60◦
NLRP1-F TCTCAGTGCCCAGGTGATTA 151 60◦
NLRP1-R TTGTCTCTGCTGCTTGAATGA 151 60◦
IPAF-F AAGGATGAAGGGCTGAAGGT 159 60◦
IPAF-R CGAAACTTGTAGGCTGACCA 159 60◦
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FIGURE 2 | Astrocytes in primary culture expresses high levels of NLRP3
mRNA. (A) mRNA expression of NLRP3, AIM2, NLRP1, and IPAF
inﬂammasomes in cultured astrocytes evaluated by RT-PCR. (B) Ethanol
treatment (10 and 50 mM) for 24 h up-regulates the NLRP3 mRNA levels in
the cultured astrocytes fromTLR4 mice.We used n = 5–7 independent
experiments and ratios were normalized with the PPIA housekeeping gene.
Bars represent the [mean ± SEM]. *p < 0.05, **p < 0.01, ***p < 0.001
(Mann–Whitney U non-parametric test or a Student’s t -test). (C) Immuno-
ﬂuorescence of NLRP3 (green) and GFAP- (red) co-localization in the
astrocytes fromTLR4 andTLR4-knockout mice. Scale bar 20 μm.
compared with untreated animals (Figures 1A,G). We also deter-
mined interleukins IL-1β and IL-18 in the Ctx of the WT and
TLR4-KO mice treated with or without ethanol for 5 months.
Figures 1I,J shows that ethanol treatment up-regulates the lev-
els of IL-1β and IL-18 in the Ctx of the WT mice. Conversely,
the same ethanol treatment neither increased caspase-1 acti-
vation (Figures 1C,D,G,H) nor the levels of IL-1β and IL-18
(Figures 1I,J) in the Ctx of TLR4-KO mice.
To gain further insight into how ethanol affects inﬂamma-
some activation and which type of inﬂammasome was activated
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in astroglial cells, we used highly enriched astrocytes in primary
culture, and the gene expression of different inﬂammasomes were
assessed. An RT-PCR analysis revealed (Figure 2A) that although
inﬂammasomes NLRP3, AIM2, NLRP1, and IPAF are expressed
in astrocytes; the NLRP3 mRNA level was higher than the other
inﬂammasomes, and the ethanol treatment (10 and 50 mM) was
capable of up-regulating the NLRP3 mRNA levels (Figure 2B).
The immunoﬂuorescence studies also revealed that the NLRP3
protein expression is expressed in the cytosol of GFAP+ cells
(Figure 2C), although higher NLRP3 expression are noted in WT
astrocytes treated with LPS, ATP or ethanol (10, 50 mM).
The assembly of the NLRP3 inﬂammasome complex required
adaptor protein ASC and its oligomerization to bring the recep-
tor and zymogen pro-caspase-1 into close proximity, which led
to caspase-1 activation, and to the cleavage of pro-IL-1β and
pro-IL-18 into their active cytokine and pyroptotic cell death
(Fernandes-Alnemri et al., 2007). Therefore, in order to evalu-
ate if ethanol, in comparison with other inﬂammasome stimuli,
was capable of inducing ASC oligomerization, the cleavage of
caspase-1 and the production of IL-1β and IL-18, astrocytes
were treated with LPS, ATP (a positive control of NLRP3 acti-
vation) and ethanol (10, 50 mM). Figure 3 shows that ethanol
and the LPS or ATP treatment promoted: (i) up-regulation of
NLRP3; (ii) caspase-1 activation, as evidenced by the appear-
ance of the 10 kDa active caspase-1-clevage peptide (Figure 3A);
(iii) ASC oligomerization, as demonstrated by the notably pres-
ence of ASC dimers and some trimers (Fernandes-Alnemri and
Alnemri, 2008; Figure 3B); (iv) the association between caspase-
1 cleavage and NLRP3, as demonstrated by the Co-IP of both
proteins with the appearance of the active p20/p10 caspase-1 in
treated-astrocytes (Figure 3C); and (v) the production of pro-
inﬂammatory cytokines IL-1β and IL-18 (Figure 3D). If we
consider that ASC is an adaptor protein required for the activation
of bothNLRP3 inﬂammasome and caspase-1 (Fernandes-Alnemri
et al., 2007), the results indicate that by inducing NLRP3 inﬂam-
masome complex activation and ASC-pyroptosome formation,
ethanol was capable of inducing the innate immune response.
Our results further suggest that activation of NLRP3/caspase-1 is
associatedwith the TLR4 function since the astrocytes fromTLR4-
KO mice presented no response or a minimal one to different
stimuli, including alcohol, on NLRP3 inﬂammasome activation
(Figures 3A–D).
ETHANOL-INDUCED MITOCHONDRIAL ROS FORMATION TRIGGERS
NLRP3 INFLAMMASOME COMPLEX ACTIVATION
One of the mechanisms by which NLRP3 inﬂammasome can
be activated is ROS generation (Tschopp and Schroder, 2010),
and mROS formation seems particularly critical for NLRP3 acti-
vation (Zhou et al., 2011). We therefore explored the potential
role of ethanol-induced mROS in NLRP3 inﬂammasome acti-
vation. To assess superoxide production by mitochondria in
cultured astrocytes, we used the MitoSOXTM Red reagent in live
cells, a ﬂuorogenic dye that speciﬁcally targets mitochondria in
live cells, and a ﬂow cytometry analysis. For these experiments,
astrocytes were treated with ethanol (10 and 50 mM), LPS and
ATP for 24 h in the presence or absence of Mito-TEMPO [a
mitochondria (m) ROS scavenger] or a Z-YVAD-FMK (speciﬁc
caspase-1 inhibitor) or z-VAD-FMK (inhibitor of caspase pro-
teases) or a NLRP3 bp. Then mROS production was measured.
The results indicate that treating WT astrocytes with ATP or LPS
or ethanol (10 mM or 50 mM) markedly induced mROS pro-
duction (Figure 4A). Notably, the mROS production induced
by ethanol (10 and 50 mM) or LPS or ATP was signiﬁcantly
abrogated by Mito-TEMPO, z-YVAD-FMK, or Z-VAD-FMK by
the presence of NLRP3 bp (Figure 4A). Strikingly, small, but
non-signiﬁcant, changes were noted in the TLR4-KO astrocytes
incubated with ATP, or LPS or ethanol (Figure 4B). These
results suggest that mROS generation induced by ATP or LPS
or ethanol mediates NLRP3/caspase-1 inﬂammasome activation.
Our ﬁndings also suggest crosstalk between TLR4 and NLRP3
inﬂammasome.
To conﬁrm the above results, we measured the levels of IL-1β
and IL-18 in the medium of astrocytes incubated for 24 h with
ATP or LPS or ethanol (10 and 50 mM), in the presence or absence
of Mito-TEMPO or z-YVAD-FMK or Z-VAD-FMK or NLRP3 bp.
According to the above results, ATP or LPS or ethanol (10 and
50 mM) treatment induces the production of IL-1β and IL-18 in
the astrocytes supernatant, while the presence of Mito-TEMPO or
z-YVAD-FMKor Z-VAD-FMKorNLRP3 bp abolishesmost of the
cytokine released in the cell medium (Figures 5A,B). However, the
results presented in Figure 5 illustrate that while both Z-YVAD-
FMK and z-VAD-FMK were more efﬁcient than NLRP3 bp or
Mito-TEMPOin inhibiting IL-18 in all the treatments, the caspase-
1 inhibitor did not completely abolish the release of IL-1β induced
by ATP or LPS or ethanol, suggesting that this cytokine may be
produced by other mechanisms (Hanamsagar et al., 2012). No
signiﬁcant variations in the levels of IL-1β or IL-18 were noted
in the TLR4-KO astrocytes treated with ATP, LPS or even ethanol
(Figures 5A,B).
INFLAMMASOME STIMULATION INDUCES CASPASE-1 AND NLRP3
RECRUITMENT WITHIN THE MITOCHONDRIA IN ASTROCYTES
Previous studies have shown that NLRP3 is located at the endo-
plasmic reticulum (ER) in the steady state and that it translocates
to the mitochondria-associated ER membranes following stimula-
tion (Zhou et al., 2011). Therefore, in order to gain further insights
into ethanol-induced NLRP3 inﬂammasome activation, we used
confocal microscopy to assess the location of NLRP3 under basal
and stimulated conditions. We noted that under basal conditions,
NLRP3 was located at the cytoplasm, but not within mitochondria
(Figure 6A). We were unable to detect caspase-1 under the steady-
state conditions. However, stimulation of astrocytes with ATP,
LPS or ethanol (10 mM) led to the recruitment of caspase-1 and
NLRP3 within mitochondria, as demonstrated by the overlap of
caspase-1 and NLRP3 in the mitochondria (mitotracker stain-
ing). Strikingly, ATP and ethanol stimulation promoted higher
caspase-1 levelswithinmitochondria thanLPS. Inhibiting caspase-
1 with Z-VAD-FMK (Figure 6B) or mROS with Mito-TEMPO
(Figure 6C)mostly abolishedNLRP3/caspase1 recruitmentwithin
mitochondria.
It is noteworthy that ATP, LPS, or ethanol (10 mM) did not
promote NLRP3/caspase-1 activation and recruitment into the
mitochondria in TLR4-KO astrocytes (Figure 6). Immunoﬂu-
orescence studies with pro-caspase-1 and NLRP3 in untreated
Frontiers in Cellular Neuroscience www.frontiersin.org August 2014 | Volume 8 | Article 216 | 8
Alfonso-Loeches et al. Ethanol activates NLRP3 in astrocytes
FIGURE 3 | Continued
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FIGURE 3 | Continued
Ethanol treatment activates the NLRP3 inflammasome complex in
cultured astrocytes fromTLR4-WT mice. (A)Western blot analysis shows
the NLRP3 and p10/caspase-1 active cleavage (the initiator caspase in
pyroptosis) protein levels in the LPS-, ATP-, and ethanol- (10 and 50 mM)
treated astrocytes. (B)We show ASC oligomerization and quantiﬁcation of
the ASC dimer by densitometry. Cells were lysed, pelleted by centrifugation
and incubated with DSS for 30 min. The cross-linked pellets were
resuspended in SDS sample buffer, and proteins were separated using 12%
SDS-PAGE andWestern blotted with anti-mouse ASC antibodies as
described under Section “Material and Methods.” The presence of dimers
and trimers was observed in the ATP-, LPS-, or ethanol-treated astrocytes
correlating with a signiﬁcative up-regulation of ASC dimers. (C) Cell lysates
were collected and co-immunoprecipitated with the NLRP3 Ab (IP), and the
immune complexes were detected byWestern blot with Caspase-1 (IB).We
show the presence of the p45 caspase-1 precursor and the active p20/p10
Caspase-1 in treated/untreated astrocytes. The mouse IgG was used as a
negative control. (D) ELISA measured determined the IL-1β and IL-18 levels
in the supernatant of the astrocytes treated with LPS, ATP and ethanol (10
and 50 mM) after 24 h. Non-signiﬁcant differences were observed between
the treated or non-treatedTLR4-KO astrocytes. Values represent the
mean ± SEM of 3–9 individual experiments. #p < 0.06, *p < 0.05,
**p < 0.01, ***p < 0.001 (Mann–Whitney U non-parametric test or a
Student’s t -test).
astrocytes and those treated with ATP, LPS and ethanol (10 mM)
from WT and TLR4-KO mice also demonstrated that while stim-
ulation with ATP, LPS or ethanol reduces the pro-caspase-1 levels
and increases NLRP3 expression (Figure 2) and its co-localization
in the WT cell cytoplasm, no changes in these parameters were
observed in untreated or treated TLR4-KO astrocytes. In short,
the results suggest that the by triggering pro-IL-1β production
(Gross et al., 2011), TLR4 acts as a priming signal which, along
with ROS production (second signal), promotes NLRP3 inﬂam-
masome activation. Lack of TLR4 signaling (TLR4-KO) was able
to abolish the production of not only pro-IL-1, but also of other
cytokineswhichmight target to themitochondria to initiatemROS
production.
ETHANOL-INDUCED NLRP3 INFLAMMASOME ACTIVATION TRIGGERS
PYROPTOSIS AND APOPTOSIS
Inﬂammasome-dependent caspase-1 activity has been shown to
cause a rapid inﬂammatory form of cell death called pyroptosis,
in which cytoplasmic content and pro-inﬂammatory cytokines,
including IL-1β and IL-18, are released (Miao et al., 2011). How-
ever, apoptosis can also be induced by mitochondria stress and
NLRP3 activation (Morizot, 2012), and our previous studies have
indicated that ethanol can cause activationof caspase-3-dependent
apoptosis and necrosis in the cerebral cortex (Alfonso-Loeches
et al., 2010). Therefore, in order to evaluate whether ethanol-
induced TLR4-dependent mitochondrial ROS production and
NLRP3 activation promote pyroptosis and/or apoptosis, treated
and untreated astrocytes were labeled with different staining
and then, the proportion of those cells that died by apoptosis,
necrosis or pyroptosis were evaluated using an In Cell Analyzer.
As shown in Figure 7A, treatment of the astrocytes with ATP
or LPS or ethanol 10 mM or ethanol 50 mM promotes 10.2,
15, 15.9, and 9.5% of pyroptosis (PI+ and FLICA 660-YVAD-
FMK+ cells), respectively, when compared with untreated control
cells.
Pyroptosis was also evaluated by measuring the levels of LDH
release upon the different treatments. The results in Figure 7B
illustrate that either ethanol or ATP treatments induces the release
of cytoplasmic LDH in the cellmedium. In all cases, pyroptosiswas
abrogated by Z-YVAD-FMK (a caspase-1 inhibitor) or Z-VAD-
FMK or Mito-TEMPO treatments (Figures 7A,B). Notably, ATP,
LPS or ethanol also induced a slight, yet signiﬁcant increase in
apoptosis (PI− cells and increased staining with Hoechst 33342
due to DNA condensation). Thus, the percentage of apoptosis
was 3.2, 3.3, 2.9, and 3.3% upon treatment with ATP, LPS or
ethanol (10 and 50 mM), respectively (Figure 7A). No signiﬁcant
or minimal changes in pyroptosis or apoptosis were observed in
treated TLR4-KO astrocytes.
Although apoptosis represents a small proportion of cell death
induced by NLRP3 inﬂammasome activation, recent evidence has
indicated that mitochondria stress can also lead to inﬂammation,
NLRP3 activation and cell death by apoptosis (Morizot, 2012).
We therefore evaluated the role of mitochondria ROS produc-
tion and apoptosome formation by assessing the levels of Apaf-1
and active peptide caspase-9/caspase-3 in the astrocytes stimu-
lated with ATP and ethanol. As shown in Figure 8A, both ATP
and ethanol (10 mM and 50 mM) increase the levels of Apaf-
1 and the active (cleaved) forms of caspase-9 and caspase-3 to
trigger apoptosis, as conﬁrmed by the TUNEL assay (Figure 8B).
These results suggest that ethanol-induced NLRP3 inﬂammasome
activation can trigger mainly pyroptosis, but may also induce
apoptosis.
DISCUSSION
Innate immune activation can occur in the nervous system in
response to infections and/or tissue damage (Lampron et al.,
2013). Two main receptors and signaling pathways are involved in
this response, membrane receptors TLRs and cytoplasm sensors
NLRPs, which regulate caspase-1 activity through inﬂammasome
formation. Activation of TLRs has been shown to participate
in brain infection and neurodegenerative disorders (Hanamsagar
et al., 2012). However, less information is available on the role of
inﬂammasome in brain damage and neuroinﬂammation, and the
cellular source of inﬂammasome activation during brain infec-
tion or injury is lacking. In this study, we show that astrocytes
express various inﬂammasomes, although NRLP3 expression is
higher. We further demonstrate that ethanol as well as ATP or LPS,
triggers the recruitment of NLRP3 and active caspase-1 within
mitochondria by inducing mROS formation, which promotes the
production of IL-1β and IL-18. The present ﬁndings also reveal
crosstalk between TLR4 and the NLRP3 inﬂammasome complex
since the elimination of the TLR4 function markedly reduces
ethanol- or ATP-induced NLRP3 inﬂammasome activation and
cytokines production.
NLRP3 is an intracellular protein complex composed of
NLRP3, ASC, and pro-caspase-1, and it serves as a platform to
activate pro-inﬂammatory cytokines IL-1β and IL-18 (Schroder
et al., 2010). Recent structural studies have revealed the impor-
tance of ASCPYD/ASCPYD and NLRP3PYD/ASCPYD interactions
during inﬂammasome activation (Lu et al., 2014). NLRP3 can
be activated by pathogens and by a wide range of cytoso-
lic DAMPs, including ATP, potassium efﬂux, alum, uric acid
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FIGURE 4 |The ethanol-induced mitochondria ROS production level
measured by MitoSOX Red fluorescence intensity. (A) A ﬂow cytometry
analysis shows that the ATP or LPS or ethanol (10 and 50 mM) treatments
increased mROS generation in theWT astrocytes. Incubation with
Z-YVAD-FMK, Z-VAD-FMK, the NLRP3 blocking peptide or Mito-TEMPO
before and during treatments notably reduces mROS generation activation in
WT astrocytes. (B) No signiﬁcant changes in mROS generation were
observed in theTLR4-KO-astrocytes incubated with the same inhibitors and
treatments as used in theTLR4-astrocytes. Bars represent the (mean ± SEM)
of 4–12 individual experiments. *p < 0.05, **p < 0.01, ***p < 0.001
(one-way ANOVA followed by a Dunnett’s Multiple ComparisonTest or a
Student’s t -test).
crystals and amyloid β (Jin and Flavell, 2010; Schroder et al.,
2010) and is also involved in the pathogenesis of metabolic
diseases, brain disorders, such as Alzheimer’s disease (Heneka
et al., 2013), autoimmune encephalomyelitis (EAE), and it also
contributes to ethanol-induced neuroinﬂammation in the cere-
bellum of ethanol-treated mice (Lippai et al., 2013). Although
the cellular and molecular mechanisms of ethanol-induced
inﬂammasome activation in the brain remain to be deﬁned,
we herein provide evidence that cultured astrocytes express
NLRP3 and are capable of promoting ASC oligomerization to
allow the recruitment of NLRP3 and caspase-1 activation (Lu
et al., 2014) along with the production of IL-1β and IL-18
in response to ethanol, ATP or LPS. Inhibition of caspase-1
by Z-YVAD-FMK abolishes the production of IL-1β and IL18,
suggesting the role of caspase-1 in NLRP3 activation and cytokine
production.
Frontiers in Cellular Neuroscience www.frontiersin.org August 2014 | Volume 8 | Article 216 | 11
Alfonso-Loeches et al. Ethanol activates NLRP3 in astrocytes
FIGURE 5 | Ethanol enhances the production of IL-18 and IL-1β inWT
astroglial cells. (A,B) Graphs represent the levels of IL-18 (A) and IL-1β (B)
measured in the supernatant medium of theWT andTLR4-KO astrocytes
treated with ATP, LPS or ethanol (10 and 50 mM) for 24 h. Incubation with
Z-YVAD-FMK, Z-VAD-FMK, the NLRP3 blocking peptide or Mito-TEMPO,
along with the different treatments, reduces, or even abolishes, the
up-regulation of the cytokine release. No changes in the levels of cytokines
were noted in the supernatant medium for theTLR4-KO-astrocytes for any of
the treatments and inhibitors used, except for the Mito-TEMPO treatment at
the IL-18 released levels. Bars represent the (mean ± SEM) expressed as a
percentage (%) of 6–10 individual experiments. *p < 0.05, **p < 0.01,
***p < 0.001 (two-way ANOVA with post hoc Bonferroni’s correction).
Notably, while microglia appear to be the main player in
NLRP3 inﬂammasome activation in the brain (Hanamsagar et al.,
2012), recent studies have independently demonstrated that rat or
human astrocytes express NLRP3 (Tezel et al., 2012) and NLRP2
(Minkiewicz et al., 2013) and are able to activate NLRP3 in
response to DAMPs. Our in vivo immunohistochemical studies
further support that in vivo ethanol treatment increases NLRP3
inﬂammasome activation in GFAP+ astroglial cells along with
the production of IL-1β and IL-18 in WT mice cerebral cortex.
According to these results, prior work from our laboratory has
shown that ethanol promotes IL-1β production in both astrocytes
(Blanco et al., 2005; Alfonso-Loeches et al., 2010) and microglia
(Fernandez-Lizarbe et al., 2009) in culture, aswell as in the cerebral
cortex of ethanol-treated mice (Alfonso-Loeches et al., 2010).
Activation of theNLRP3 inﬂammasome by diverse stimuli usu-
ally requires two signals (Gross et al., 2011): the ﬁrst signal, or
priming signal is usually induced by TLRs/LPS signaling which
triggers pro-IL-1β; and a second signal, induced by a diverse
array of stimuli (e.g., ROS, ion membrane perturbations, ATP,
etc.) and different mechanisms (Martinon, 2007; Petrilli et al.,
2007; Qu et al., 2007). Recent evidence supported the critical role
of mROS generation in NLRP3 activation (Nakahira et al., 2011;
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FIGURE 6 | Confocal images of NLRP3/caspase-1 co-localization within
mitochondria of the astrocytes treated with ethanol, ATP, or LPS.
Microphotographs show that the ATP, LPS, or ethanol (10 mM) treatments
promote the co-localization of NLRP3 inﬂammasome (blue) with active
caspase-1 (green) within mitochondria (red) in theWT-astrocytes when
compared with the untreated control astrocytes (A). Astrocytes treated with
Z-VAD-FMK (B) and with Mito-TEMPO (C) treatments do not induce
caspase-1 activation in bothWT andTLR4-KO astrocytes.We performed at
least three independent experiments under each experimental condition.
Representative pictures are presented.
Shimada et al., 2012b). According to these ﬁndings, here we show
that ethanol, similarly to other NLRP3 activators like ATP or LPS
(Sutterwala et al., 2006), is capable of inducing mROS generation
in astrocytes by triggeringNLRP3 inﬂammasome activation, along
with active caspase-1 maturation and the production of IL-1β and
IL-18. The role of mROS in NLRP3 inﬂammasome activation
has been supported by data demonstrating that blocking mROS
or NLRP3, or the inhibition of caspase-1, abrogates both mROS
generation and the up-regulation of IL-1β and IL-18 induced by
ATP, LPS or ethanol. Indeed, previous studies demonstrate that
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FIGURE 7 | Activation of the NLRP3 inflammasome complex triggers
pyroptosis and apoptosis in ethanol-induced astroglial cells. (A) Bars
show the percentage of cell dead by pyroptosis, necrosis and apoptosis in
astrocytes treated for 24 h with ATP, LPS, and ethanol (10 and 50 mM)
evaluated by an In Cell Analyzer. Approximately 1000–5000 cells were
analyzed/experimental condition. Bars represent the (mean ± SD). (B) LDH
activity in the supernatant astrocytes was measured with different
treatments. Bars represent the (mean ± SEM) of at least 6–10 individual
experiments. *p < 0.05, **p < 0.01 (Mann–Whitney U non-parametric
test).
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FIGURE 8 | Ethanol can also induce the apoptosome formation
in astrocytes. (A) The Western blot analyses of Apaf-1, the active
fragments from caspase-9 (37 kDa) and caspase-3 (17 kDa), in the
astrocytes treated with ATP (5 μM) or ethanol (10 and 50 mM). Bars
represent the (mean ± SEM) of at least 6–10 individual experiments.
*p < 0.05, **p < 0.01 (Mann–Whitney U non-parametric test or a
Student’s t -test). (B) The percentage of apoptosis in the astrocytes
incubated with ATP or ethanol (10 mM, 50 mM) for 24 h was
assessed by a TUNEL assay in the WT and TLR4-KO astrocytes.
Scale bar: 20 μm. Arrowheads show different apoptotic processes,
blebbing and nuclei condensation. Asterisk show positive TUNEL cells.
Bars represent the (mean ± SEM) of three individual experiments.
*p < 0.05, **p < 0.01 (two-way ANOVA with post hoc Bonferroni’s
correction).
ethanol-induced mROS generation participate in ethanol toxicity
in both astrocytes (Gonzalez et al., 2007) and liver (Manzo-Avalos
and Saavedra-Molina, 2010).
Cell death is ultimately caused by cellular innate immune
response elicited by the inﬂammasome activation. We show that
the activation of NLRP3 by either ATP, LPS or ethanol mainly
triggers pyroptosis a caspase-1-dependent inﬂammatory form of
programmed cells in which dying cells release their cytoplasmic
content, including cytokines, into the extracellular space. Nev-
ertheless, ethanol or ATP by inducing mitochondrial stress and
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mROS production, can also trigger apoptosis by activating Apaf-1,
caspase-9, and caspase-3, and the apoptosome complex (Morizot,
2012). It is noteworthy that inﬂammasomes and apoptosomes
are two mechanisms of the immune cells by which compromised
cells are eliminated and share many similarities in their regula-
tory response to cellular stress (Latz et al., 2013). Yet whether these
two mechanisms act independently or are linked, and whether
their individual contributions depend on the intensity and type
of cell stimuli (e.g., bacteria, virus, DAMPs; Doitsh et al., 2014),
are uncertain (Latz et al., 2013). Nevertheless, in vivo evidence
from the immunohistochemical data reported herein (Figure 1)
and our previous studies support the in vitro ﬁnding since we
observed that chronic ethanol treatment increases IL-1β levels and
induces both apoptosis and caspase-3 activation, as well as necro-
sis, in the WT mice but not in the TLR4-KO mice cerebral cortex
(Alfonso-Loeches et al., 2010).
Indeed, the present ﬁndings also support the role of TLR4
signaling in ethanol-induced NLRP3 activation, since the elimi-
nation of the TLR4 function in astrocytes abolishes ethanol- or
ATP-induced NLRP3 activation. As commented above, a crosstalk
between TLRs and inﬂammasome (Hanamsagar et al., 2012) has
been reported. Activation of TLRs and the production of pro-
IL-1β is the priming step for NLRP3 activation (Gross et al.,
2011). Then, a second signal, induced by a diverse stimuli (e.g.,
ROS, ion membrane perturbations, ATP, etc.), promotes ASC-
inﬂammasome oligomerization, caspase-1 activation, followed by
the maturation and secretion of IL-1β and IL-18. A recent report
has suggested that NLRP3 is activated by a two-step, deubiqui-
tination mechanism initiated by TLRs signaling and mROS and
that it is further potentiated by ATP, events which might explain
how NLRP3 is activated by diverse danger signals (Juliana et al.,
2012). Therefore, the lack of TLR4 function in TLR4-KO astro-
cytes not only eliminates the priming signal, as production of
pro-IL-1β, but also the production of cytokines and free radicals-
mediated by TLR4 signaling. These later events could, sensitize
the mitochondria to induce ROS production and consequently
NLRP3 activation and cell death by pyroptosis and apoptosis.
Accordingly, recent evidence has demonstrated that TLR4 signal-
ing induce mitochondria ROS production, contributing to the
gastric cancer progression (Yuan et al., 2013). The functional role
of TLR4 in the inﬂammasome activation is further supported by
the demonstration that TLR4 deﬁciency not only protects ethanol-
induced NLRP3 inﬂammasome activation and the induction of
cytokines, but also attenuates the increased in ethanol-induced
IL-1β production in the cerebellum (Lippai et al., 2013). We also
noted that in vivo ethanol treatment abolishes the induction of
IL-18 and IL-1β production in the cerebral cortex of TLR4-KO
mice.
The role of TLR4 in ethanol-induced neuroinﬂammation and
brain damage has been clearly demonstrated. Our previous stud-
ies have shown that by interacting with membrane microdomains
“lipid rafts” in glial cells, ethanol can induce TLR4 dimerization
and signaling to trigger the release of cytokines and inﬂam-
matory mediators (Blanco et al., 2005, 2008; Fernandez-Lizarbe
et al., 2009). By using small interfering RNA (siRNA) or cells
from TLR4-deﬁcient mice (TLR4-KO), knockdown TLR4, abol-
ish MAPK and NFk-B signaling pathways and the release of
inﬂammatory mediators in glial cells (Fernandez-Lizarbe et al.,
2009; Alfonso-Loeches et al., 2010). The in vivo relevance of these
ﬁndings is evidenced by the demonstration that while chronic
ethanol intake causes neuroinﬂammation, gliosis, demyelina-
tion and cell death (apoptosis and necrosis) in the cerebral
cortex, TLR4-KO mice are protected against ethanol-induced
brain inﬂammatory mediators, cell death and brain injury
(Alfonso-Loeches et al., 2010, 2012). The present ﬁndings further
support the role of TLR4 in ethanol-induced NLRP3 inﬂamma-
some activation and IL-1β and IL-18 production in glial cells,
events that contribute to ethanol-induced neuroinﬂammation.
To support our results, a recent study has demonstrated that
ethanol-impaired neurogenesis is associated with induction of
IL-1β and with inﬂammasome NALP1 and NALP3 activation
in both neurons and astrocytes, and that these events can be
blocked with both the IL-1β receptor and antagonist rIL-1Ra
(Zou and Crews, 2012). Similarly, the intracranial administra-
tion of IL-1Ra prevents alcohol-induced inﬂammasome activation
and the up-regulation of IL-1β and TNF-α in the cerebel-
lum of ethanol-treated mice (Lippai et al., 2013). These results
indicate the importance of ethanol-induced inﬂammasome acti-
vation and IL-1β production in the neuroinﬂammatory effects of
ethanol.
CONCLUSION
Taken together, our results demonstrate for the ﬁrst time that, by
promoting mROS generation, ethanol induces NLRP3/caspase-1
activation to trigger IL-1β/IL-18 production and cell death by
pyroptosis and apoptosis, events that could contribute to neu-
roinﬂammation and brain damage induced by ethanol abuse. We
further show crosstalk between NLRP3 and TLR4 since the elim-
ination of TLR4 markedly diminishes ethanol actions on NLRP3
inﬂammasome activation and the production of the inﬂammatory
cytokines IL-1β/IL-18. Our ﬁndings suggest that inﬂammasome
activation may represent a new target in ethanol-induced neu-
roinﬂammation, and they support the potential role of IL-1Ra in
the treatment of the neuropathological changes associated with
alcohol abuse.
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